MedPath

深圳华药南方制药有限公司

Ownership
-
Established
1987-10-23
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Biapenem for Injection

Product Name
注射用比阿培南
Approval Number
国药准字H20233792
Approval Date
Jun 27, 2023
NMPA

Aztreonam for Injection

Product Name
注射用氨曲南
Approval Number
国药准字H20084040
Approval Date
Mar 14, 2023
NMPA

Azithromycin Lactobionate for Injection

Product Name
注射用乳糖酸阿奇霉素
Approval Number
国药准字H20084229
Approval Date
Mar 14, 2023
NMPA

Azithromycin Lactobionate for Injection

Product Name
注射用乳糖酸阿奇霉素
Approval Number
国药准字H20084228
Approval Date
Mar 14, 2023
NMPA

Aztreonam for Injection

Product Name
注射用氨曲南
Approval Number
国药准字H20084041
Approval Date
Mar 14, 2023
NMPA

Lysine Acetylsalicylate for Injection

Product Name
注射用赖氨匹林
Approval Number
国药准字H20084118
Approval Date
Mar 14, 2023
NMPA

Lysine Acetylsalicylate for Injection

Product Name
注射用赖氨匹林
Approval Number
国药准字H20084117
Approval Date
Feb 23, 2023
NMPA

Streptomycin Sulfate for Injection

Product Name
注射用硫酸链霉素
Approval Number
国药准字H20083235
Approval Date
Feb 23, 2023
NMPA

Lysine Acetylsalicylate for Injection

Product Name
注射用赖氨匹林
Approval Number
国药准字H20084119
Approval Date
Feb 23, 2023
NMPA

Meropenem for Injection

Product Name
注射用美罗培南
Approval Number
国药准字H20217096
Approval Date
Nov 2, 2021
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.